| Somatic mosaic IDH1 and IDH2 mutations are associated with enchondroma and spindle cell hemangioma in Ollier disease and Maffucci syndrome TC Pansuriya, R van Eijk, P d'Adamo, MAJH van Ruler, ML Kuijjer, ... Nature genetics 43 (12), 1256-1261, 2011 | 599 | 2011 |
| Somatic mutations in angiopoietin receptor gene TEK cause solitary and multiple sporadic venous malformations N Limaye, V Wouters, M Uebelhoer, M Tuominen, R Wirkkala, JB Mulliken, ... Nature genetics 41 (1), 118-124, 2009 | 495 | 2009 |
| Suppressed NFAT-dependent VEGFR1 expression and constitutive VEGFR2 signaling in infantile hemangioma M Jinnin, D Medici, L Park, N Limaye, Y Liu, E Boscolo, J Bischoff, ... Nature medicine 14 (11), 1236-1246, 2008 | 446 | 2008 |
| Somatic activating PIK3CA mutations cause venous malformation N Limaye, J Kangas, A Mendola, C Godfraind, MJ Schlögel, R Helaers, ... The American Journal of Human Genetics 97 (6), 914-921, 2015 | 322 | 2015 |
| Association of extensive polymorphisms in the SLAM/CD2 gene cluster with murine lupus AE Wandstrat, C Nguyen, N Limaye, AY Chan, S Subramanian, XH Tian, ... Immunity 21 (6), 769-780, 2004 | 318 | 2004 |
| Rapamycin improves TIE2-mutated venous malformation in murine model and human subjects E Boscolo, N Limaye, L Huang, KT Kang, J Soblet, M Uebelhoer, ... The Journal of clinical investigation 125 (9), 3491-3504, 2015 | 257 | 2015 |
| Blue rubber bleb nevus (BRBN) syndrome is caused by somatic TEK (TIE2) mutations J Soblet, J Kangas, M Nätynki, A Mendola, R Helaers, M Uebelhoer, ... Journal of Investigative Dermatology 137 (1), 207-216, 2017 | 227 | 2017 |
| Hereditary cutaneomucosal venous malformations are caused by TIE2 mutations with widely variable hyper-phosphorylating effects V Wouters, N Limaye, M Uebelhoer, A Irrthum, LM Boon, JB Mulliken, ... European Journal of Human Genetics 18 (4), 414-420, 2010 | 187 | 2010 |
| Variable somatic TIE2 mutations in half of sporadic venous malformations J Soblet, N Limaye, M Uebelhoer, LM Boon, M Vikkula Molecular syndromology 4 (4), 179-183, 2013 | 185 | 2013 |
| From germline towards somatic mutations in the pathophysiology of vascular anomalies N Limaye, LM Boon, M Vikkula Human molecular genetics 18 (R1), R65-R74, 2009 | 134 | 2009 |
| Classification of vascular anomalies: an update JE Steiner, BA Drolet Seminars in interventional radiology 34 (03), 225-232, 2017 | 128 | 2017 |
| Venous malformation-causative TIE2 mutations mediate an AKT-dependent decrease in PDGFB M Uebelhoer, M Nätynki, J Kangas, A Mendola, HL Nguyen, J Soblet, ... Human molecular genetics 22 (17), 3438-3448, 2013 | 121 | 2013 |
| Common and specific effects of TIE2 mutations causing venous malformations M Nätynki, J Kangas, I Miinalainen, R Sormunen, R Pietilä, J Soblet, ... Human molecular genetics 24 (22), 6374-6389, 2015 | 109 | 2015 |
| PDGFRB gain-of-function mutations in sporadic infantile myofibromatosis FA Arts, R Sciot, B Brichard, M Renard, A de Rocca Serra, G Dachy, ... Human molecular genetics 26 (10), 1801-1810, 2017 | 97 | 2017 |
| Susceptibility genes in the pathogenesis of murine lupus C Nguyen, N Limaye, EK Wakeland Arthritis Research 4 (Suppl 3), S255-63, 2002 | 81 | 2002 |
| Vascular anomalies caused by abnormal signaling within endothelial cells: targets for novel therapies HL Nguyen, LM Boon, M Vikkula Seminars in interventional radiology 34 (03), 233-238, 2017 | 68 | 2017 |
| Liquid biopsy for mutational profiling of locoregional recurrent and/or metastatic head and neck squamous cell carcinoma R Galot, C van Marcke, R Helaers, A Mendola, RM Goebbels, X Caignet, ... Oral oncology 104, 104631, 2020 | 63 | 2020 |
| Association of PDGFRB mutations with pediatric myofibroma and myofibromatosis G Dachy, RR De Krijger, S Fraitag, I Théate, B Brichard, SB Hoffman, ... JAMA dermatology 155 (8), 946-950, 2019 | 62 | 2019 |
| B cell–intrinsic CD84 and Ly108 maintain germinal center B cell tolerance EB Wong, C Soni, AY Chan, PP Domeier, S Shwetank, T Abraham, ... The Journal of Immunology 194 (9), 4130-4143, 2015 | 52 | 2015 |
| Liquid biopsy to detect minimal residual disease: methodology and impact N Honoré, R Galot, C van Marcke, N Limaye, JP Machiels Cancers 13 (21), 5364, 2021 | 51 | 2021 |
